Literature DB >> 26637899

Cancer Incidence in Patients with Atypical Endometrial Hyperplasia Managed by Primary Hysterectomy or Fertility-sparing Treatment.

Clémentine Gonthier1, Bruno Piel2, Cyril Touboul2, Francine Walker3, Annie Cortez4, Dominique Luton1, Emile Daraï5, Martin Koskas1.   

Abstract

AIM: To compare the risk of developing endometrial carcinoma (EC) in young women with atypical endometrial hyperplasia (AEH) undergoing fertility-sparing management compared to women treated by primary hysterectomy. PATIENTS AND METHODS: In this multicentric retrospective study, 111 patients with a diagnosis of AEH by endometrial biopsy were included. EC incidence was compared in two groups: 32 patients treated with fertility-sparing management and 79 older patients treated with primary hysterectomy.
RESULTS: The rates of EC diagnosed by pathology of hysterectomy specimens were comparable between the groups. The probability of developing EC at 12, 24 and 36 months were 14%, 21% and 26%, respectively, in patients managed conservatively, and 29%, 37% and 37%, respectively, in patients treated with primary hysterectomy.
CONCLUSION: Fertility-sparing management of AEH does not increase the risk of diagnosing EC from the hysterectomy specimen. Copyright
© 2015 International Institute of Anticancer Research (Dr. John G. Delinassios), All rights reserved.

Entities:  

Keywords:  Fertility-sparing management; atypical endometrial hyperplasia; endometrial cancer; progression risk

Mesh:

Year:  2015        PMID: 26637899

Source DB:  PubMed          Journal:  Anticancer Res        ISSN: 0250-7005            Impact factor:   2.480


  3 in total

1.  Endometrial Cancer Incidence in Patients With Atypical Endometrial Hyperplasia According to Mode of Management.

Authors:  Anas Barakat; Aemn Ismail; Supratik Chattopadhyay; Quentin Davies
Journal:  Cancer Diagn Progn       Date:  2022-09-03

2.  Concurrent and future risk of endometrial cancer in women with endometrial hyperplasia: A systematic review and meta-analysis.

Authors:  Michelle T Doherty; Omolara B Sanni; Helen G Coleman; Chris R Cardwell; W Glenn McCluggage; Declan Quinn; James Wylie; Úna C McMenamin
Journal:  PLoS One       Date:  2020-04-28       Impact factor: 3.240

3.  Simultaneous FTIR and Raman Spectroscopy in Endometrial Atypical Hyperplasia and Cancer.

Authors:  Edyta Barnas; Joanna Skret-Magierlo; Andrzej Skret; Ewa Kaznowska; Joanna Depciuch; Kamil Szmuc; Kornelia Łach; Izabela Krawczyk-Marć; Jozef Cebulski
Journal:  Int J Mol Sci       Date:  2020-07-08       Impact factor: 5.923

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.